Interferon-gamma regulation of C3 gene expression in human astroglioma cells

J Neuroimmunol. 1992 Jun;38(3):275-82. doi: 10.1016/0165-5728(92)90020-l.

Abstract

In this report, we show that the human astroglioma cell line, D54-MG, constitutively expresses C3 mRNA and secretes antigenically detectable C3 protein. The cytokine interferon-gamma (IFN-gamma) enhances C3 mRNA and protein expression by D54-MG cells in a dose- and time-dependent manner. C3 mRNA from both D54-MG cells and primary human adult astrocytes has the same apparent size (5.1-5.2 kb) as C3 mRNA from hepatocyte and monocyte cell lines. Constitutive C3 mRNA levels in D54-MG cells and primary human astrocytes are comparable. Primary rat astrocytes also constitutively express C3 mRNA, which is enhanced upon exposure to IFN-gamma. These data are novel since expression of C3 in other cell types is refractory to IFN-gamma. In the central nervous system (CNS), endogenous complement production by astrocytes, and enhancement by the cytokine IFN-gamma, may contribute to the pathogenesis of inflammatory demyelinating diseases such as multiple sclerosis (MS).

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Astrocytes / metabolism
  • Astrocytoma / genetics*
  • Astrocytoma / metabolism
  • Astrocytoma / pathology
  • Complement C3 / genetics*
  • Complement C3 / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Interferon-gamma / pharmacology*
  • Kinetics
  • RNA, Messenger / metabolism
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • Complement C3
  • RNA, Messenger
  • Interferon-gamma